Results 51 to 60 of about 7,288 (241)

Mucoviscidose com sintomatologia respiratória no período neonatal.

Acta Médica Portuguesa, 1997
A case of cystic fibrosis presented in the neonatal period with respiratory symptomatology associated with early pancreatic insufficiency is reported. The CFTR gene molecular analysis was found to be a compound heterozygotes for delta F508 and G542X. The
S Lamy, L P da Silva, B Lopes, P Pacheco, J Lavinha, J M Amaral, J M Marques   +6 more
doaj   +1 more source

Perspective of the European Cystic Fibrosis Society on Improving Global Cystic Fibrosis Care

Pediatric Pulmonology, Volume 61, Issue 7, July 2026.
ABSTRACT Introduction Outcomes for people with the inherited disease, cystic fibrosis, have improved greatly over the last few decades, but one result of this is a widening gap between regions with high income and well‐resourced healthcare systems and low/middle income countries.
Jane C. Davies, Egil Bakkeheim, Audrey Chansard, Pavel Drevinek, Christine Dubois, Jess Matthews, Marta Sheremet, Chris Smith   +7 more
wiley   +1 more source

Registre Français de la Mucoviscidose. Bilan des données 2016 [PDF]

, 2016
Objectifs L’association Vaincre la Mucoviscidose a mis en place en 1992 un Observatoire National de la Mucoviscidose (ONM) ayant les objectifs suivants : – améliorer la connaissance des caractéristiques médicales et sociales, – mieux appréhender le coût
Lemonnier, Lydie, Dehillotte, Clémence, Bellis, Gil   +2 more
core  

La mucoviscidose au temps du confinement ou l'exacerbation des inégalités sociales ? [PDF]

, 2020
Rapport remis au Centre de Ressources et de Compétences de la Mucoviscidose du CHI de ...
Bégot, Anne-Cécile
core  

Trans-Atlantic collaboration: applying lessons learned from the US CF Foundation quality improvement initiative

Orphanet Journal of Rare Diseases, 2018
Background Between 2002 and 2006 France launched a national cystic fibrois (CF) newborn screening program; organized a network of specialized CF care centers; and issued CF diagnostic and treatment standards.
Kathryn A. Sabadosa, Marjorie M. Godfrey, Bruce C. Marshall   +2 more
doaj   +1 more source

Lung organoids as a human system for Mycobacteria infection modeling and drug testing

The FEBS Journal, Volume 293, Issue 6, Page 1587-1611, March 2026.
Mycobacterial infections, including tuberculosis (TB) and infections by nontuberculous mycobacteria (NTM), are still public health issues. In 2023, TB caused 1.25 million deaths, while NTM remain a clinical challenge for patients with cystic fibrosis (CF).
Stephen Adonai Leon‐Icaza, Romain Vergé, Raoul Mazars, Laurence Berry, Céline Cougoule   +4 more
wiley   +1 more source

A intersubjetividade no contexto da família de pessoas com fibrose cística

Revista Brasileira de Enfermagem, 2012
Trata-se de uma investigação qualitativa, com aproximação fenomenológica, que objetivou desvelar os processos intersubjetivos no contexto da família de pessoas com Fibrose Cística (FC).
Geisa Santos Luz, Silvana Sidney Costa Santos, Valéria Lerch Lunardi, Ellen Dayane Cargnin Pimentel, Sandra Marisa Pelloso, Maria Dalva de Barros Carvalho   +5 more
doaj   +1 more source

Implementation of Model-Based Dose Adjustment of Tobramycin in Adult Patients with Cystic Fibrosis

Pharmaceutics, 2022
Therapeutic drug monitoring (TDM) of tobramycin is widely performed in patients with cystic fibrosis (CF), but little is known about the value of model-informed precision dosing (MIPD) in this setting.
Jérémy Reverchon, Vianney Tuloup, Romain Garreau, Viviane Nave, Sabine Cohen, Philippe Reix, Stéphane Durupt, Raphaele Nove-Josserand, Isabelle Durieu, Quitterie Reynaud, Laurent Bourguignon, Sandrine Charles, Sylvain Goutelle   +12 more
doaj   +1 more source

The validated French CFAbd‐Score reveals a lower burden of gastrointestinal symptoms in patients on Elexacaftor/Tezacaftor/Ivacaftor

Journal of Pediatric Gastroenterology and Nutrition, Volume 82, Issue 1, Page 24-32, January 2026.
Abstract Objectives Multiorgan abdominal involvement is a hallmark of Cystic fibrosis (CF). The CFAbd‐Score© is the first CF‐specific gastrointestinal patient reported outcome‐measure (PROM) developed following FDA‐guidelines. The PROM has proved to sensitively differentiate people with CF (pwCF) from healthy controls (HC).
Isabelle Sermet‐Gaudelus, Pauline Sadrieh, Anne Sophie Bonnel, Raphael Enaud, Nathalie Wizla, Jeanne Languepin, Ambre Nangui, Audrey Deelawon, Johanna Rave, Samira Dabelow, Anton Barucha, Carlos Zagoya, Franziska Duckstein, Jochen Georg Mainz   +13 more
wiley   +1 more source

Mucoviscidose: apresentação de um caso. [PDF]

, 1982
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Pediatria, Curso de Medicina, Florianópolis ...
Maresch, Bruno A
core